Qingdao Central Hospital
Qingdao Central Hospital
Explore linked clinical trials.10 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification | EGFR Positive Non-small Cell Lung Cancer; MET Amplification | Recruiting | Phase 2 | 2026-01-07 | NCT07322783 | |
| Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions | Overall Response Rate | Recruiting | Phase 2 | 2025-07-29 | NCT07090525 | |
| Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer | EFS; pCR Rate | Active, not recruiting | Phase 2 | 2025-07-29 | NCT07090031 | |
| QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Not yet recruiting | Phase 2 | 2025-06-06 | NCT07009145 | |
| Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, leukemia, neoplasm | Not yet recruiting | Not stated | 2024-10-18 | NCT06649422 | |
| Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, mouth disorder, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease, stomatitis | Recruiting | Not applicable | 2024-08-07 | NCT05892354 | |
| Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 / Phase 3 | 2024-07-24 | NCT06138028 | |
| Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer | Neoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Residual Tumor, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Not stated | 2024-07-23 | NCT06514118 | |
| Nutrition Impact on Immunotherapy of Cancer | Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Prosthesis Failure, Prosthesis Survival, cancer, neoplasm, nutritional disorder | Recruiting | Phase 3 | 2024-07-15 | NCT06500234 | |
| Colchicine Use for Primary Prevention of Coronary Artery Disease | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Not yet recruiting | Phase 3 | 2022-03-21 | NCT05175274 |